BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tyndall V, Stimson RH, Zammitt NN, Ritchie SA, McKnight JA, Dover AR, Gibb FW. Marked improvement in HbA1c following commencement of flash glucose monitoring in people with type 1 diabetes. Diabetologia 2019;62:1349-56. [PMID: 31177314 DOI: 10.1007/s00125-019-4894-1] [Cited by in Crossref: 51] [Cited by in F6Publishing: 43] [Article Influence: 17.0] [Reference Citation Analysis]
Number Citing Articles
1 Shi L, Hellmund R; Tulane University, New Orleans, LA, USA, Abbott Diabetes Care, Alameda, CA, USA. Cost Comparison of Flash Continuous Glucose Monitoring with Self-monitoring of Blood Glucose in Adults with Type 1 or Type 2 Diabetes Using Intensive Insulin—From a US Private Payer Perspective. US Endocrinology 2020;16:24. [DOI: 10.17925/use.2020.16.1.24] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
2 Deshmukh H, Wilmot EG, Gregory R, Barnes D, Narendran P, Saunders S, Furlong N, Kamaruddin S, Banatwalla R, Herring R, Kilvert A, Patmore J, Walton C, Ryder REJ, Sathyapalan T. Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit. Diabetes Care 2020;43:2153-60. [PMID: 32669277 DOI: 10.2337/dc20-0738] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 9.5] [Reference Citation Analysis]
3 Prigge R, McKnight JA, Wild SH; Scottish Diabetes Research Network Epidemiology Group. International comparison of glycaemic control in people with type 1 diabetes: an update and extension. Diabet Med 2021;:e14766. [PMID: 34890078 DOI: 10.1111/dme.14766] [Reference Citation Analysis]
4 Bailey TS, Alva S. Landscape of Continuous Glucose Monitoring (CGM) and Integrated CGM: Accuracy Considerations. Diabetes Technol Ther 2021;23:S5-S11. [PMID: 34546084 DOI: 10.1089/dia.2021.0236] [Reference Citation Analysis]
5 Hirsch IB, Miller E. Integrating Continuous Glucose Monitoring Into Clinical Practices and Patients' Lives. Diabetes Technol Ther 2021;23:S72-80. [PMID: 34546085 DOI: 10.1089/dia.2021.0233] [Reference Citation Analysis]
6 Miller E, Midyett LK. Just Because You Can, Doesn't Mean You Should … Now. A Practical Approach to Counseling Persons with Diabetes on Use of Optional CGM Alarms. Diabetes Technol Ther 2021;23:S66-71. [PMID: 34546081 DOI: 10.1089/dia.2021.0192] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Hansen KW. Effects of unrestricted access to flash glucose monitoring in type 1 diabetes. Endocrinol Diabetes Metab 2020;3:e00125. [PMID: 32704551 DOI: 10.1002/edm2.125] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Alhodaib HI, Alsulihem S. Factors influencing the effectiveness of using flash glucose monitoring on glycemic control for type 1 diabetes in Saudi Arabia. World J Diabetes 2021; 12(11): 1908-1916 [PMID: 34888015 DOI: 10.4239/wjd.v12.i11.1908] [Reference Citation Analysis]
9 Galindo RJ, Parkin CG, Aleppo G, Carlson AL, Kruger DF, Levy CJ, Umpierrez GE, McGill JB. What's Wrong with This Picture? A Critical Review of Current Centers for Medicare & Medicaid Services Coverage Criteria for Continuous Glucose Monitoring. Diabetes Technol Ther 2021. [PMID: 33844588 DOI: 10.1089/dia.2021.0107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Boscari F, Avogaro A. Current treatment options and challenges in patients with Type 1 diabetes: Pharmacological, technical advances and future perspectives. Rev Endocr Metab Disord 2021;22:217-40. [PMID: 33755854 DOI: 10.1007/s11154-021-09635-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Galindo RJ, Aleppo G. Continuous glucose monitoring: The achievement of 100 years of innovation in diabetes technology. Diabetes Res Clin Pract 2020;170:108502. [PMID: 33065179 DOI: 10.1016/j.diabres.2020.108502] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 5.5] [Reference Citation Analysis]
12 Reddy M, Oliver N. Self-Monitoring of Blood Glucose Requirements with the Use of Intermittently Scanned Continuous Glucose Monitoring. Diabetes Technol Ther 2020;22:235-8. [PMID: 31833786 DOI: 10.1089/dia.2019.0369] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Elbalshy M, Boucher S, Galland B, Haszard JJ, Crocket H, Wiltshire E, Jefferies C, de Bock MI, Tomlinson P, Jones S, Wheeler BJ. The MiaoMiao study: can do-it-yourself continuous glucose monitoring technology improve fear of hypoglycaemia in parents of children affected by type 1 diabetes? J Diabetes Metab Disord 2020;19:1647-58. [PMID: 33553041 DOI: 10.1007/s40200-020-00671-5] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Bailey CJ, Gavin JR 3rd. Flash Continuous Glucose Monitoring: A Summary Review of Recent Real-World Evidence. Clin Diabetes 2021;39:64-71. [PMID: 33551555 DOI: 10.2337/cd20-0076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Gáborová M, Doničová V, Bačová I, Pallayová M, Bona M, Peregrim I, Grešová S, Štimmelová J, Dzugasová B, Šalamonová Blichová L, Donič V. Glycaemic Variability and Risk Factors of Pregnant Women with and without Gestational Diabetes Mellitus Measured by Continuous Glucose Monitoring. Int J Environ Res Public Health 2021;18:3402. [PMID: 33806005 DOI: 10.3390/ijerph18073402] [Reference Citation Analysis]
16 Gavin JR, Bailey C. Real-World Studies Support Use of CGM in Type 1 and Type 2 Diabetes Independently of Treatment Regimen. Diabetes Technol Ther 2021. [PMID: 34165343 DOI: 10.1089/dia.2021.0211] [Reference Citation Analysis]
17 Bosi E, Gregori G, Cruciani C, Irace C, Pozzilli P, Buzzetti R. The use of flash glucose monitoring significantly improves glycemic control in type 2 diabetes managed with basal bolus insulin therapy compared to self-monitoring of blood glucose: A prospective observational cohort study. Diabetes Res Clin Pract 2021;183:109172. [PMID: 34883185 DOI: 10.1016/j.diabres.2021.109172] [Reference Citation Analysis]
18 Rose L, Klausmann G, Seibold A. Improving HbA1c Control in Type 1 or Type 2 Diabetes Using Flash Glucose Monitoring: A Retrospective Observational Analysis in Two German Centres. Diabetes Ther 2021;12:363-72. [PMID: 33314006 DOI: 10.1007/s13300-020-00978-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
19 Tsur A, Cahn A, Israel M, Feldhamer I, Hammerman A, Pollack R. Impact of flash glucose monitoring on glucose control and hospitalization in type 1 diabetes: A nationwide cohort study. Diabetes Metab Res Rev 2021;37:e3355. [PMID: 32469094 DOI: 10.1002/dmrr.3355] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
20 Ang E, Lee ZX, Moore S, Nana M. Flash glucose monitoring (FGM): A clinical review on glycaemic outcomes and impact on quality of life. Journal of Diabetes and its Complications 2020;34:107559. [DOI: 10.1016/j.jdiacomp.2020.107559] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
21 Draznin B, Aroda VR, Bakris G, Benson G, Brown FM, Freeman R, Green J, Huang E, Isaacs D, Kahan S, Leon J, Lyons SK, Peters AL, Prahalad P, Reusch JEB, Young-Hyman D, Das S, Kosiborod M; American Diabetes Association Professional Practice Committee., American Diabetes Association Professional Practice Committee:. 7. Diabetes Technology: Standards of Medical Care in Diabetes-2022. Diabetes Care 2022;45:S97-S112. [PMID: 34964871 DOI: 10.2337/dc22-S007] [Reference Citation Analysis]
22 Stimson RH, Dover AR, Ritchie SA, Wright RJ, McKnight JA, Zammitt NN, Gibb FW. HbA1c response and hospital admissions following commencement of flash glucose monitoring in adults with type 1 diabetes. BMJ Open Diabetes Res Care 2020;8:e001292. [PMID: 32719078 DOI: 10.1136/bmjdrc-2020-001292] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
23 Gordon I, Rutherford C, Makarounas-kirchmann K, Kirchmann M. Meta-analysis of average change in laboratory-measured HbA1c among people with type 1 diabetes mellitus using the 14 day Flash Glucose Monitoring System. Diabetes Research and Clinical Practice 2020;164:108158. [DOI: 10.1016/j.diabres.2020.108158] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
24 Roussel R, Riveline JP, Vicaut E, de Pouvourville G, Detournay B, Emery C, Levrat-Guillen F, Guerci B. Important Drop Rate of Acute Diabetes Complications in People With Type 1 or Type 2 Diabetes After Initiation of Flash Glucose Monitoring in France: The RELIEF Study. Diabetes Care 2021:dc201690. [PMID: 33879536 DOI: 10.2337/dc20-1690] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
25 Lameijer A, Fokkert MJ, Edens MA, Gans ROB, Bilo HJG, van Dijk PR. Two-year use of flash glucose monitoring is associated with sustained improvement of glycemic control and quality of life (FLARE-NL-6). BMJ Open Diabetes Res Care 2021;9:e002124. [PMID: 34521652 DOI: 10.1136/bmjdrc-2021-002124] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Dover AR, Strachan MWJ, McKnight JA, Stimson RH, Mackenzie SD, Lyall MJ, Wright RJ, Forbes S, Gibb FW. Socioeconomic deprivation, technology use, C-peptide, smoking and other predictors of glycaemic control in adults with type 1 diabetes. Diabet Med 2021;38:e14445. [PMID: 33128811 DOI: 10.1111/dme.14445] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
27 Frank JR, Blissett D, Hellmund R, Virdi N. Budget Impact of the Flash Continuous Glucose Monitoring System in Medicaid Diabetes Beneficiaries Treated with Intensive Insulin Therapy. Diabetes Technol Ther 2021;23:S36-44. [PMID: 34546079 DOI: 10.1089/dia.2021.0263] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Battelino T, Edelman SV, Nishimura R, Bergenstal RM. Comparison of Second-Generation Basal Insulin Analogs: A Review of the Evidence from Continuous Glucose Monitoring. Diabetes Technol Ther 2021;23:20-30. [PMID: 32700970 DOI: 10.1089/dia.2020.0180] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Wada E, Onoue T, Kobayashi T, Handa T, Hayase A, Ito M, Furukawa M, Okuji T, Okada N, Iwama S, Sugiyama M, Tsunekawa T, Takagi H, Hagiwara D, Ito Y, Suga H, Banno R, Kuwatsuka Y, Ando M, Goto M, Arima H. Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Res Care 2020;8:e001115. [PMID: 32518063 DOI: 10.1136/bmjdrc-2019-001115] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
30 Broos B, Charleer S, Bolsens N, Moyson C, Mathieu C, Gillard P, De Block C. Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK. J Clin Endocrinol Metab 2021;106:e3037-48. [PMID: 33740049 DOI: 10.1210/clinem/dgab188] [Reference Citation Analysis]
31 Gibb FW, McKnight JA, Clarke C, Strachan MWJ. Preserved C-peptide secretion is associated with fewer low-glucose events and lower glucose variability on flash glucose monitoring in adults with type 1 diabetes. Diabetologia 2020;63:906-14. [PMID: 32034440 DOI: 10.1007/s00125-020-05099-3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 18] [Article Influence: 7.5] [Reference Citation Analysis]
32 Sehgal S, De Bock M, Williman J, Taylor B, Elbalshy M, Galland B, Hall R, Paul R, Boucsein A, Jones S, Frewen C, Wheeler BJ. Study protocol: Safety and efficacy of smart watch integrated do-it-yourself continuous glucose monitoring in adults with Type 1 diabetes, a randomised controlled trial. J Diabetes Metab Disord 2021;20:2103-13. [PMID: 34900846 DOI: 10.1007/s40200-021-00923-y] [Reference Citation Analysis]
33 Li A, Hussain S. Diabetes technologies - what the general physician needs to know. Clin Med (Lond) 2020;20:469-76. [PMID: 32934039 DOI: 10.7861/clinmed.2020-0034] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
34 Dover AR, Ritchie SA, McKnight JA, Strachan MWJ, Zammitt NN, Wake DJ, Forbes S, Stimson RH, Gibb FW. Assessment of the effect of the COVID-19 lockdown on glycaemic control in people with type 1 diabetes using flash glucose monitoring. Diabet Med 2021;38:e14374. [PMID: 32740984 DOI: 10.1111/dme.14374] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 8.5] [Reference Citation Analysis]
35 McClure Yauch L, Velazquez E, Piloya-Were T, Wainaina Mungai L, Omar A, Moran A. Continuous glucose monitoring assessment of metabolic control in east African children and young adults with type 1 diabetes: A pilot and feasibility study. Endocrinol Diabetes Metab 2020;3:e00135. [PMID: 32704558 DOI: 10.1002/edm2.135] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
36 Hansen KW, Bibby BM. The Frequency of Intermittently Scanned Glucose and Diurnal Variation of Glycemic Metrics. J Diabetes Sci Technol 2021;:19322968211019382. [PMID: 34041961 DOI: 10.1177/19322968211019382] [Reference Citation Analysis]
37 Nolan T, Frazzitta M. Insurance Coverage for Emerging Diabetes Technologies: Payers' Perspective. Diabetes Technol Ther 2021;23:S28-35. [PMID: 34546078 DOI: 10.1089/dia.2021.0262] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
38 Wysham CH, Kruger DF. Practical Considerations for Initiating and Utilizing Flash Continuous Glucose Monitoring in Clinical Practice. J Endocr Soc 2021;5:bvab064. [PMID: 34291180 DOI: 10.1210/jendso/bvab064] [Reference Citation Analysis]
39 Nathanson D, Svensson AM, Miftaraj M, Franzén S, Bolinder J, Eeg-Olofsson K. Effect of flash glucose monitoring in adults with type 1 diabetes: a nationwide, longitudinal observational study of 14,372 flash users compared with 7691 glucose sensor naive controls. Diabetologia 2021;64:1595-603. [PMID: 33774713 DOI: 10.1007/s00125-021-05437-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Hansen KW, Bibby BM. Glycemic Metrics Derived From Intermittently Scanned Continuous Glucose Monitoring. J Diabetes Sci Technol. [DOI: 10.1177/1932296820975822] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
41 Lameijer A, Fokkert MJ, Edens MA, Slingerland RJ, Bilo HJG, van Dijk PR. Determinants of HbA1c reduction with FreeStyle Libre flash glucose monitoring (FLARE-NL 5). J Clin Transl Endocrinol 2020;22:100237. [PMID: 33102135 DOI: 10.1016/j.jcte.2020.100237] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
42 Nørgaard SK, Mathiesen ER, Nørgaard K, Ringholm L. Comparison of Glycemic Metrics Measured Simultaneously by Intermittently Scanned Continuous Glucose Monitoring and Real-Time Continuous Glucose Monitoring in Pregnant Women with Type 1 Diabetes. Diabetes Technol Ther 2021. [PMID: 34086494 DOI: 10.1089/dia.2021.0109] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Secher AL, Pedersen-Bjergaard U, Svendsen OL, Gade-Rasmussen B, Almdal T, Raimond L, Vistisen D, Nørgaard K. Flash glucose monitoring and automated bolus calculation in type 1 diabetes treated with multiple daily insulin injections: a 26 week randomised, controlled, multicentre trial. Diabetologia 2021;64:2713-24. [PMID: 34495375 DOI: 10.1007/s00125-021-05555-8] [Reference Citation Analysis]
44 Lameijer A, Lommerde N, Dunn TC, Fokkert MJ, Edens MA, Kao K, Xu Y, Gans ROB, Bilo HJG, van Dijk PR. Flash Glucose Monitoring in the Netherlands: Increased monitoring frequency is associated with improvement of glycemic parameters. Diabetes Res Clin Pract 2021;177:108897. [PMID: 34098059 DOI: 10.1016/j.diabres.2021.108897] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
45 Edelman SV, Cavaiola TS, Boeder S, Pettus J. Utilizing continuous glucose monitoring in primary care practice: What the numbers mean. Prim Care Diabetes 2021;15:199-207. [PMID: 33257275 DOI: 10.1016/j.pcd.2020.10.013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
46 Fokkert M, van Dijk P, Edens M, Barents E, Mollema J, Slingerland R, Gans R, Bilo H. Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4). BMJ Open Diabetes Res Care 2019;7:e000809. [PMID: 31875133 DOI: 10.1136/bmjdrc-2019-000809] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
47 Timmons JG, Boyle JG, Petrie JR. Time in Range as a Research Outcome Measure. Diabetes Spectr 2021;34:133-8. [PMID: 34149253 DOI: 10.2337/ds20-0097] [Reference Citation Analysis]
48 Linton K, Stimson RH, Dover AR, Forbes S, Madill K, Annoh R, Strachan MWJ, McKnight JA, Wright RJ, Gibb FW. Substantial HbA1c Reduction Following Intermittent-Scanning Continuous Glucose Monitoring Was Not Associated With Early Worsening of Retinopathy in Type 1 Diabetes. J Diabetes Sci Technol 2021;:1932296821994091. [PMID: 33605149 DOI: 10.1177/1932296821994091] [Reference Citation Analysis]
49 Wen X, Ou T, Zeng N, Li X, Luo A, Xu X, Li W, Du T. Clinical interpretation of the flash continuous glucose monitoring data out of range in type 2 diabetes: A real-world study. Diabetes Res Clin Pract 2021;178:108989. [PMID: 34331978 DOI: 10.1016/j.diabres.2021.108989] [Reference Citation Analysis]
50 Jeyam A, Gibb FW, McKnight JA, O'Reilly JE, Caparrotta TM, Höhn A, McGurnaghan SJ, Blackbourn LAK, Hatam S, Kennon B, McCrimmon RJ, Leese G, Philip S, Sattar N, McKeigue PM, Colhoun HM; Scottish Diabetes Research Network Epidemiology Group. Flash monitor initiation is associated with improvements in HbA1c levels and DKA rates among people with type 1 diabetes in Scotland: a retrospective nationwide observational study. Diabetologia 2021. [PMID: 34618177 DOI: 10.1007/s00125-021-05578-1] [Reference Citation Analysis]
51 Secher AL, Pedersen-Bjergaard U, Svendsen OL, Gade-Rasmussen B, Almdal TP, Dørflinger L, Vistisen D, Nørgaard K. Study protocol for optimising glycaemic control in type 1 diabetes treated with multiple daily insulin injections: intermittently scanned continuous glucose monitoring, carbohydrate counting with automated bolus calculation, or both? A randomised controlled trial. BMJ Open 2020;10:e036474. [PMID: 32345699 DOI: 10.1136/bmjopen-2019-036474] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
52 Lin R, Brown F, James S, Jones J, Ekinci E. Continuous glucose monitoring: A review of the evidence in type 1 and 2 diabetes mellitus. Diabet Med 2021;38:e14528. [PMID: 33496979 DOI: 10.1111/dme.14528] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
53 Deshmukh H, Wilmot EG, Gregory R, Barnes D, Narendran P, Saunders S, Furlong N, Kamaruddin S, Banatwalla R, Herring R, Kilvert A, Patmore J, Walton C, Ryder REJ, Sathyapalan T. Predictors of diabetes-related distress before and after FreeStyle Libre-1 use: Lessons from the Association of British Clinical Diabetologists nationwide study. Diabetes Obes Metab 2021;23:2261-8. [PMID: 34142425 DOI: 10.1111/dom.14467] [Reference Citation Analysis]
54 Al-Dalla Ali M, Stimson RH, Dover AR, Forbes S, Annoh R, Madill K, Gibb FW. HbA1c reduction following flash monitoring commencement is not independently associated with adverse diabetic eye disease outcomes in type 1 diabetes. BMJ Open Diabetes Res Care 2020;8:e001668. [PMID: 33132212 DOI: 10.1136/bmjdrc-2020-001668] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
55 Unger J, Kushner P, Anderson JE. Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care. Postgrad Med 2020;132:305-13. [PMID: 32223687 DOI: 10.1080/00325481.2020.1744393] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
56 Canecki Varzic S, Steiner K, Gradinjan Centner M, Grgurevic M, Cigrovski Berkovic M, Klobucar Majanovic S, Radman M, Milicevic T, Rahelic D, Bilic Curcic I. Assessment of FreeStyle Libre Flash Glucose Monitoring System Implementation in Real Life Clinical Setting: A Prospective Observational Study. Diagnostics (Basel) 2021;11:305. [PMID: 33668675 DOI: 10.3390/diagnostics11020305] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]